NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Start Multiple Choice Practice Test
Start Flash Cards

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

How often must an Assessment of Risk be reviewed for drugs with lower risk?

  1. Every 6 months

  2. At least every 12 months

  3. Every 2 years

  4. Every month

The correct answer is: At least every 12 months

An Assessment of Risk must be reviewed regularly in order to ensure the safety and efficacy of a drug. While an Assessment of Risk for higher risk drugs may need to be reviewed every 6 months or even monthly, for drugs with lower risk, a review at least every 12 months is sufficient. This is because lower risk drugs typically have a lower likelihood of causing adverse effects and therefore require less frequent monitoring and assessment. Options A, C, and D are incorrect because they suggest review frequencies that are either too frequent or too infrequent for drugs with lower risk.

More Questions Like This